Cannabinoid Encyclopedia Plain-English research
New here? Search a cannabinoid or health question. Read the simple version. Open PubMed links when you want proof. This is education, not medical advice.

Dictionary / Safety

Drug interaction

A safety topic connecting cannabinoids with medicines, enzymes, or clinical monitoring.

Dictionary A-Z Evidence Method
Safetyterm category
6related public pages
editorial navigationdefinition status
draftreview status
11exact evidence rows
11exact source links
105nearby evidence rows
90nearby source links
0do-not-confuse links
0entity links

This page is a dictionary definition and navigation aid. Exact evidence rows below come from approved workbench claims; broader claims and citations live on the related source-backed pages.

Dictionary Reader Map

Use the definition as a doorway, not a conclusion.

Drug interaction explains vocabulary used across the cannabinoid encyclopedia. The definition orients the reader; exact rows and related pages carry the source-backed claims.

Definition Role Safety

Safety terms keep risk, population, product, and co-exposure context visible.

Exact Evidence 11 rows

11 direct sources linked to approved workbench claims. PubMed 36206805

Nearby Graph 6 pages

105 nearby evidence rows and 90 nearby source links.

Also Search cyp enzymes, cyp interaction, drug interactions, medicine interaction

Aliases help readers find the same concept without changing the evidence standard.

Plain-Language Definition

What it means here

Drug interaction is used in this encyclopedia as a safety term. A safety topic connecting cannabinoids with medicines, enzymes, or clinical monitoring.

Safety terms should stay close to population, dose, product, route, medicine-use, and adverse-event context. They should be read as risk-mapping language, not personal medical guidance.

Also searched as: cyp enzymes, cyp interaction, drug interactions, medicine interaction.

Evidence Guardrail

How to read it without overreaching

Safety pages are heightened-context pages. Population, dose, route, co-medications, pregnancy, pediatrics, impairment, and adverse-event details matter before any evidence is generalized.

Evidence Lens

What this term can currently point to

Exact rows 11

Direct approved claim rows linked to this dictionary term. PubMed 36206805

Exact sources 11

Distinct source records under those exact rows. PubMed 36206805

Related pages 6

Source-backed public pages where this vocabulary is likely useful. Open related page

Nearby rows 105

Evidence rows available on those related public pages. Open related page

Exact rows are direct evidence links. Use them first, then use related pages to understand the broader research context.

Source Path

How to move from this definition to research

  1. Read the definition.Use it to understand the vocabulary in plain English.
  2. Check exact rows.When direct rows exist, open the linked PubMed or DOI record. PubMed 36206805
  3. Open related pages.Use nearby pages for broader source-backed context. Related page
  4. Keep the boundary.Safety vocabulary is not personal medical advice; population and co-medication context matter.

Exact Evidence Rows

Approved source-backed rows linked to this term

Evidence method

11 exact rows

Evidence Group

Insufficient

9 exact rows / 9 sources

Evidence row 22 / safety context

CBD interacts with drug or class drug-interaction mechanisms or safety-relevant outcomes.

insufficient / very_low confidence.

Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. PubMed 36206805

Predicate describes a drug interaction.

Evidence row 23 / safety context

CBD interacts with drug or class drug-interaction mechanisms or safety-relevant outcomes.

insufficient / very_low confidence.

Cannabidiol's impact on drug-metabolization. PubMed 37541924

Predicate describes a drug interaction.

Evidence row 24 / safety context

CBD interacts with drug or class drug-interaction mechanisms or safety-relevant outcomes.

insufficient / very_low confidence.

A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication. PubMed 35156171

Predicate describes a drug interaction.

Evidence row 48 / safety context

CBD interacts with drug or class drug-interaction mechanisms or safety-relevant outcomes.

insufficient / very_low confidence.

Memantine for autism spectrum disorder. PubMed 36006807

Predicate describes a drug interaction.

Evidence row 49 / safety context

CBD interacts with drug or class drug-interaction mechanisms or safety-relevant outcomes.

insufficient / very_low confidence.

Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. PubMed 39007525

Predicate describes a drug interaction.

Evidence row 50 / safety context

CBD interacts with drug or class drug-interaction mechanisms or safety-relevant outcomes.

insufficient / very_low confidence.

Antiseizure medications for Lennox-Gastaut Syndrome: Comprehensive review and proposed consensus treatment algorithm. PubMed 39854828

Predicate describes a drug interaction.

Evidence row 51 / safety context

CBD interacts with drug or class drug-interaction mechanisms or safety-relevant outcomes.

insufficient / very_low confidence.

Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. PubMed 31288397

Predicate describes a drug interaction.

Evidence row 52 / safety context

CBD interacts with drug or class drug-interaction mechanisms or safety-relevant outcomes.

insufficient / very_low confidence.

Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs. PubMed 32918835

Predicate describes a drug interaction.

Evidence row 1068 / safety context

Anandamide studied for anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms.

insufficient / very_low confidence.

Endocannabinoid metabolism by cytochrome P450 monooxygenases. PubMed 25461979

Claim or source metadata contains an explicit term marker.

Back to evidence groups

Evidence Group

Mechanistic or Pharmacological

2 exact rows / 2 sources

Evidence row 47 / safety context

CBD interacts with drug or class drug-interaction mechanisms or safety-relevant outcomes.

mechanistic or pharmacological / very_low confidence.

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects. PubMed 30374683

Predicate describes a drug interaction.

Evidence row 533 / safety context

CBN studied for Skin and inflammatory dermatology.

mechanistic or pharmacological / very_low confidence.

Distinct Interactions of Cannabinol and Its Cytochrome P450-Generated Metabolites with Receptors and Sensory Neurons. PubMed 40568800

Claim or source metadata contains an explicit term marker.

Back to evidence groups

Source-Backed Connections

Related pages in the current encyclopedia

All terms
safety Drug interactions 35 evidence rows / 22 sources safety Liver enzymes and hepatotoxicity 17 evidence rows / 15 sources topic Cannabinoids and liver enzyme/hepatotoxicity safety review 12 evidence rows / 12 sources topic CBD and drug-interaction safety review 9 evidence rows / 9 sources target CYP enzymes 16 evidence rows / 16 sources topic Endocannabinoid enzyme research summary 16 evidence rows / 16 sources

Nearby Terms

Same dictionary category

Adverse event369 rows